Biomarin Pharmaceutical Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
All right. Great. So welcome, everyone, to Credit Suisse's 30th Annual Healthcare Conference. I'm Tiago Fauth. I'm a biotech analyst here at Credit Suisse. We're joined today by BioMarin. I have JJ on the line, Jeff and Brian. So I appreciate you guys participating.
Feel free to e-mail me any questions that you might have, and I'll try to work those into the fireside chat. The e-mail is [email protected]. And as usual, we can probably get started with some broad remarks, a recap of the year, key focus areas, and we'll start to go into a little bit more detail after that. But J.J., I don't know if you want to take it away.
Okay. Thank you. Thank you, Tiago. We appreciate the opportunity to join you today. So with just a few weeks left in 2021, we look forward to 2022 with great excitement as we consider the growth opportunity ahead, with potential U.S
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
